[1] Hiroyoshi J, Yamashita S, Tanaka M, Hayashi A, Ushiku T, Kaneko J,
Akamatsu N, Arita J, Sakamoto Y, Hasegawa K. Contrast-enhanced
intraoperative ultrasound in the resection of colorectal liver metastases with
intrabiliary growth. Clinical Journal of Gastroenterol. 2018;11(5):348-353.
[2] Kim KA, Kim MJ, Jeon HM, Kim KS, Choi JS, Ahn SH, Cha SJ, Chung
YE. Prediction of microvascular invasion of hepatocellular carcinoma:
usefulness of peritumoral hypointensity seen on gadoxetate disodiumenhanced hepatobiliary phase images. Journal of Magnetic Resonance
Imaging. 2012;35(3):629-34.
[3] Huang M, Liao B, Xu P, Cai H, Huang K, Dong Z, Xu L, Peng Z, Luo Y,
Zheng K, Peng B, Li ZP, Feng ST. Prediction of Microvascular Invasion in
Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced
MRI and Histopathological Correlation. Contrast Media MOI Imaging
Published online 2018 Jan 23. doi: 10.1155/2018/9674565.
[4] Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically
guided
subsegomentectomy. Surgical Gynecology and Obstetrics .1985;161:346-350.
[5] Dutton SJ, Kenealy N, Love SB, Wasan HS, Sharma RA, FOXFIRE
57
Protocol Development Group and the NCRI Colorectal Clinical Study Group.
FOXFIRE protocol: an open-label, randomised, phase III trial of 5fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without
interventional Selective Internal Radiation Therapy (SIRT) as first-line
treatment for patients with unresectable liver-only or liver-dominant
metastatic colorectal cancer. BMC Cancer.2014;14:497.
[6] Kopetz S, Chang GJ, Overman MJ, Eng C, Sarget DJ, Larson DW, Grothey
A, Vauthey JN, Nagorney D, McWilliams RR. Improved survival in metastatic
colorectal cancer is associated with adoption of hepatic resection and
improved chemotherapy. Journal of Clinical Oncology.2009;27(22):3677-3683.
[7] Saiura A, Yamamoto J, Hasegawa K, Koga R, Sakamoto Y, Hata S,
Makuuchi M, Kokudo N. Liver resection for multiple colorectal liver
metastases with surgery up-front approach: bi-institutional analysis of 736
consecutive cases. World Journal of Surgery.2012;36(9):2171-2178.
[8] Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P,
Bechstein WO, Primrose JN, Walpole ET, Jones MF, Jaeck D, Mirza D, Parks
RW, Collette L, Parget M, Bethe U, Cutsem EV, Scheithauer W, Gruenberger
T, EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research Onkologie
58
(ALM-CAO),
Australasian
Gastro-Intestinal
Trials
Group
(AGITG),
Fédération Francophone de Cancérologie Digestive (FFCD) . Perioperative
chemotherapy with FOLFOX4 and surgery versus surgery alone for
resectable liver metastases from colorectal cancer (EORTC Intergroup trial
40983): a randomised controlled trial. Lancet 2008;371(9617):1007-1016.
[9] Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Barbon C,
Beer A, Kamphues C, Løes IM, He J, Pawlik TM, Kaczirek K, Poultsides G,
Lønning PE, Cameron JL, Mischinger HJ, Aucejo FN, Kreis ME, Christopher
LW, Weiss MJ. Prognostic factors change over time after hepatectomy for
colorectal liver metastases: a multi-institutional, international analysis of
1099 patients. Ann Surg.2018;269(6):1129-1137.
[10] de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti
MA, Aldrighetti L, Capussotti L, Pawlik TM. Rates and patterns of recurrence
following curative intent surgery for colorectal liver metastasis: an
international multi-institutional analysis of 1669 patients. Annals of Surgery
2009;250(3):440-8.
[11] Helling TS, Martin M. Cause of death from liver metastases in colorectal
cancer. Annnals of Surgical Oncology. 2014;21(2):501-6.
59
[12] Yasui K, Hirai T, Kato T, Torii A, Uesaka K, Morimoto T, Kodera Y,
Yamamura Y, Kito T, Hamajima N. A new macroscopic classification predicts
prognosis for patient with liver metastases from colorectal cancer. Ann
Surg.1997;226(5):582-586.
[13] Okano K, Yamamoto J, Moriya Y, Akasu T, Kosuge T, Sakamoto M,
Hirohashi S. Macroscopic intrabiliary growth of liver metastases from
colorectal cancer. Surgery.1999;126(5):829-834
[14] Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conard C.
Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves
Salvageability and Survival. Annals of Surgery. 2016;263(1):146-152
[15] Sugiura T, Nagino M, Oda K, Ebata T, Nishio H, Arai T, Nimura Y.
Hepatectomy for colorectal liver metastases with macroscopic intrabiliary
tumor growth. World Journal of Surgery.2006;30(10):1902-1908
[16] Kubo M, Sakamoto M, Fukushima N, Yachida S, Nakanishi Y, Shimoda
T, Yamamoto J, Moriya Y, Hirohashi S. Less aggressive features of colorectal
cancer with liver metastases showing macroscopic intrabiliary extension.
Pathology International.2002;52(8):514-518
[17] Yamamoto J, Sugihara K, Kosuge T, Takayama T, Shimada K, Yamasaki
60
S, Sakamoto M, Hirohashi S. Pathologic support for limited hepatectomy in
the treatment of liver metastases from colorectal cancer. Annals of
Surgery.1995;221(1):74-78
[18] Povoski SP, Klimstra DS, Brown KT, Schwartz LH, Kurtz RC, Jarnagin
WR, Fong Y, Blumgart LH. Recognition of intrabiliary hepatic metastases
from colorectal adenocarcinoma. HPB Surgery. 2000;11(6):383-390
[19] Estrella JS, Othman ML, Taggart MW, Hamilton SR, Curley SA, Rashid
A, Abraham SC. Intrabiliary growth of liver metastases: clinicopathologic
features, prevalence, and outcome. American Journal of Surgical Pathology.
2013; 37(10):1571-1579
[20] Kokudo N, Miki Y, Sugai S,Yanagisawa A, Kato Y, Sakamoto Y,
Yamamoto J, Yamaguchi T, Muto T, Makuuchi M. Genetic and Histological
Assessment of Surgical Margins in Resected Liver Metastases From
Colorectal Carcinoma. Archives of Surgery.2002;137(7):833-840
[21] Viganò L, Costa G, Cimino MM, Procopio F, Donadon M, Fabbro DD,
Belghiti J, Kokudo N, Makuuchi M, Vauthey JN, Torzilli G. R1 Resection for
Colorectal Liver Metastases: a Survey Questioning Surgeons about Its
Incidence, Clinical Impact, and Management. Journal of Gastrointestinal
61
Surgery.2018;22(10):1752-1763
[22] Dindo D, Demartines N, Clavien PA. Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336 patients
and results of a survey. Annals of Surgery 2004;240(2):205-13.
[23] Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick
RD, de Santibañes E, Pekolj Juan, Slankamenac K, Bassi C, Graf R,
Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien–Dindo
classification of surgical complications: five-year experience. Ann Surg.
2009;250(2):187-96.
[24] Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE,
Fleming JB, Katz MH. Ninety-day postoperative mortality is a legitimate
measure
of
hepatopancreatobiliary
surgical
quality.
Ann
Surg
2015;262(6):1071-8.
[25] Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M,
Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M,
Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N. Adjuvant
oral uracil-tegafur with leucovorin for colorectal cancer liver metastases: a
randomized controlled trial. PLOS One.2016;11(9):e0162400.
62
[26] Hiroyoshi J, Arita J, Gonoi W, Akamatsu N, Kaneko J, Hasegawa K.
Significance of Glisson's capsule invasion in patients with colorectal liver
metastases
undergoing
resection.
American
Journal
of
Surgery.2019;218(5):887-893
[27] Hussain M, Waqas O, Hassan U, Loya A, Akhtar N, Mushtaq S, Yusuf
MA, Syed AA. Right-sided and left-sided colon cancers are two distinct
disease entities: an analysis of 200 cases in Pakistan. Asian Pacific Journal
of Cancer Prevention. 2016;17(5):2545-2548.
[28] Ishihara S, Murono K, Sasaki K, Yasuda K, Otani K, Nishikawa T,
Tanaka T, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Sugihara K, Watanabe
T. Impact of primary tumor location on postoperative recurrence and
subsequent prognosis in nonmetastatic colon cancers: a multicenter
retrospective
study
using
propensity
score
analysis.
Annals
of
Surgery.2018;267(5):917-921.
[29] Viganó L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G, Fabbro
DD, Torzilli G. Is Tumor Detachment from Vascular Structures Equivalent to
R0 Resection in Surgery for Colorectal Liver Metastases?. Annals of Surgical
Oncology.2016;23(4):1352-1360.
63
[30] Procopio F, Viganó L, Cimino M, Donadon M, Fabbro DD, Torsilli. Does
KRAS mutation status impact the risk of local recurrence after R1 vascular
resection for colorectal liver metastasis? An observational cohort study.
European Journal of Surgical Oncology.2020;46(5):818-824.
[31] Okano K, Yamamoto J, Okabayashi T, Sugawara Y, Shimada K, Kosuge
T, Yamasaki S, Furukawa H, Muramatsu Y.CT imaging of intrabiliary growth
of colorectal liver metastases: a comparison of pathological findings of
resected specimens. British Journal of Radiology.2002;75(894):497-501.
[32] Arita J, Ono Y, Takahashi M, Inoue Y, Takahashi Y, Matsueda K, Saiura
A. Routine preoperative liver-specific magnetic resonance imaging does not
exclude the necessity of contrast-enhanced intraoperative ultrasound in
hepatic
resection
for
colorectal
liver
metastasis.
Annals
of
Surgery.2015;262(6):1086-91.
[33] Takahashi M, Hasegawa K, Arita J, Hata S, Aoki T, Sakamoto Y,
Sugawara Y, Kokudo N. Contrast-enhanced intraoperative ultrasonography
using perfluorobutane microbubbles for the enumeration of colorectal liver
metastases. British Journal of Surgery. 2012;99(9):1271-1277.
[34] Latorre Fragua RA, Manuel Vazquez A, Rodrigues Figueira Y, Ramiro
64
Pérez C, López Marcano AJ, de la Plaza Llamas R, Ramia Ángel JM.
Intrabiliary metastases in colorectal cancer: a systematic review. Journal of
Hepato-Biliary-Pancreatic Sciences.2019; 26(7):270-280.
[35] Zhu P, Liao W, Ding ZY, Luo HC, Zhang BH, Zhang WG, Zhang W, Zhang
ZG, Zhang BX, Chen XP. Intraoperative ultrasonography of robot-assisted
laparoscopic hepatectomy: initial experiences from 110 consecutive cases.
Surgical Endoscopy.2018; 32(10):4071-4077.
[36] Harada N, Ishizawa T, Muraoka A, Ichiji M, Kusaka K, Shibasaki M,
Yamamoto K, Hasegawa K, Bandai Y, Kokudo N. Fluorescence Navigation
Hepatectomy by Visualization of Localized Cholestasis from Bile Duct. 2010;
Journal of American College of Surgeons.2010;210(6):e2-6.
[37] Muga T, Ishizawa T, Mise Y, Inoue Y, Ito H, Takahashi Y, Saiura A.
Applications of fusion-fluorescence imaging using indocyanine green in
laparoscopic hepatectomy. Surgical Endoscopy.2017;31(12):5111-5118
65
研究１
＜発表＞
2019 年 6 月 3 日
第 13 回
E-AHPBA(European-African Hepato-Pancreato-
Biliary Association)総会で発表
2019 年 6 月 15 日 第 31 回
日本肝胆膵外科学会学術集会で発表
＜論文＞
Hiroyoshi J, Arita J, Gonoi W, Akamatsu N, Kaneko J, Hasegawa K.
Significance of Glisson's capsule invasion in patients with colorectal liver
metastases
undergoing
resection.
American
Journal
of
Surgery.2019;218(5):887-893
研究２
＜発表＞
2020 年 8 月 14 日
第 120 回
日本外科学会定期学術集会で発表、Young
Investigator’s Award 受賞
2020 年 11 月 27 日～29 日
第 13 回
Pancreato-Biliary Association）総会で発表
66
IHPBA（International Hepato-
＜論文＞
Hiroyoshi J, Ishizawa T, Abe H, Arita J, Akamatsu N, Kaneko J, Ushiku T,
Hasegawa K. Identification of Glisson’s capsule invasion during hepatectomy
for colorectal liver metastasis by contrast-enhanced ultrasonography using
perflubutane. World Journal of Surgery.2020 in press
67
...
論文の公開元へ
